ZA200302947B - Treatment of premature ejaculation. - Google Patents

Treatment of premature ejaculation. Download PDF

Info

Publication number
ZA200302947B
ZA200302947B ZA200302947A ZA200302947A ZA200302947B ZA 200302947 B ZA200302947 B ZA 200302947B ZA 200302947 A ZA200302947 A ZA 200302947A ZA 200302947 A ZA200302947 A ZA 200302947A ZA 200302947 B ZA200302947 B ZA 200302947B
Authority
ZA
South Africa
Prior art keywords
inhibitor
pdes
use according
inhibitors
ethyl
Prior art date
Application number
ZA200302947A
Other languages
English (en)
Inventor
Mitradev Boolell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA200302947B publication Critical patent/ZA200302947B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200302947A 2000-11-20 2003-04-15 Treatment of premature ejaculation. ZA200302947B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0028245.9A GB0028245D0 (en) 2000-11-20 2000-11-20 New therapeutic use

Publications (1)

Publication Number Publication Date
ZA200302947B true ZA200302947B (en) 2004-04-28

Family

ID=9903491

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200302947A ZA200302947B (en) 2000-11-20 2003-04-15 Treatment of premature ejaculation.

Country Status (21)

Country Link
EP (1) EP1335730B1 (es)
JP (1) JP2004520279A (es)
KR (1) KR100595807B1 (es)
CN (1) CN1474692A (es)
AT (1) ATE296631T1 (es)
AU (2) AU2002215149B2 (es)
BR (1) BR0115413A (es)
CA (1) CA2429114C (es)
DE (1) DE60111254T2 (es)
ES (1) ES2240537T3 (es)
GB (1) GB0028245D0 (es)
HU (1) HUP0301915A3 (es)
IL (1) IL155521A0 (es)
MX (1) MXPA03003586A (es)
MY (1) MY131573A (es)
NZ (1) NZ525167A (es)
PL (1) PL362058A1 (es)
PT (1) PT1335730E (es)
TW (1) TWI280132B (es)
WO (1) WO2002040027A1 (es)
ZA (1) ZA200302947B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
AT512084A1 (de) 2011-10-20 2013-05-15 Univ Wien Tech Diazabicyclo- und diazaspiro-alkanderivate als phosphodiesterase-5 inhibitoren
EP3646871A1 (en) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Treatment and prevention of premature ejaculation (pe)
CN111297869A (zh) * 2020-04-23 2020-06-19 白文智 一种用于治疗早泄和勃起功能障碍的复方制剂

Also Published As

Publication number Publication date
DE60111254T2 (de) 2006-05-04
BR0115413A (pt) 2003-10-07
JP2004520279A (ja) 2004-07-08
ATE296631T1 (de) 2005-06-15
NZ525167A (en) 2005-02-25
CA2429114A1 (en) 2002-05-23
GB0028245D0 (en) 2001-01-03
DE60111254D1 (de) 2005-07-07
KR100595807B1 (ko) 2006-07-03
AU1514902A (en) 2002-05-27
EP1335730B1 (en) 2005-06-01
WO2002040027A1 (en) 2002-05-23
TWI280132B (en) 2007-05-01
HUP0301915A3 (en) 2007-03-28
CN1474692A (zh) 2004-02-11
CA2429114C (en) 2007-09-11
HUP0301915A2 (hu) 2003-09-29
PL362058A1 (en) 2004-10-18
EP1335730A1 (en) 2003-08-20
ES2240537T3 (es) 2005-10-16
KR20030048476A (ko) 2003-06-19
IL155521A0 (en) 2003-11-23
MXPA03003586A (es) 2003-07-14
PT1335730E (pt) 2005-09-30
MY131573A (en) 2007-08-30
AU2002215149B2 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
US20080153841A1 (en) Treatment of premature ejaculation
US20050065158A1 (en) Treatment of sexual dysfunction
US20020165237A1 (en) Treatment of the insulin resistance syndrome
CA2419033A1 (en) Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
US20020143015A1 (en) Treatment of diabetes mellitus
EP1125582A2 (en) Use of estrogen agonists / antagonists for the treatment of sexual dysfunction
AU6665000A (en) Treatment of neuropathy
CA2532252A1 (en) Treatment of sexual dysfunction
WO2003066061A1 (en) Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
US20030055070A1 (en) Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of selective serotonin reuptake inhibitor (SSR) induced sexual dysfunction
CA2429114C (en) Treatment of premature ejaculation
AU2002215149A1 (en) Treatment of premature ejaculation
AU2003242895A1 (en) Combination of PDE5 inhibitors with angiotensin II receptor antagonists
US20040132731A1 (en) Novel combination
JP4533590B2 (ja) 脊髄損傷患者における疼痛又は痙性軽減用医薬組成物
Brampton PrRAN™-SILDENAFIL